Bharati Devi Kochar, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Inflammatory Bowel Diseases | 32 | 2024 | 2428 | 6.550 |
Why?
|
Colitis, Ulcerative | 17 | 2023 | 1911 | 2.760 |
Why?
|
Crohn Disease | 14 | 2023 | 2304 | 1.910 |
Why?
|
Gastrointestinal Agents | 4 | 2022 | 494 | 1.480 |
Why?
|
Proctocolectomy, Restorative | 5 | 2023 | 189 | 1.240 |
Why?
|
Gastroenterology | 2 | 2022 | 538 | 1.020 |
Why?
|
Polypharmacy | 3 | 2024 | 294 | 0.980 |
Why?
|
Short Bowel Syndrome | 2 | 2018 | 345 | 0.960 |
Why?
|
Colonic Pouches | 2 | 2023 | 121 | 0.780 |
Why?
|
Depressive Disorder | 3 | 2018 | 3747 | 0.760 |
Why?
|
Pouchitis | 4 | 2023 | 62 | 0.760 |
Why?
|
Esophagitis | 1 | 2021 | 152 | 0.710 |
Why?
|
Meningitis | 1 | 2021 | 216 | 0.690 |
Why?
|
Videoconferencing | 1 | 2021 | 195 | 0.650 |
Why?
|
Pyoderma Gangrenosum | 1 | 2018 | 76 | 0.610 |
Why?
|
Telephone | 1 | 2021 | 617 | 0.600 |
Why?
|
Geriatrics | 1 | 2022 | 397 | 0.580 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 2 | 2023 | 504 | 0.580 |
Why?
|
Opportunistic Infections | 1 | 2020 | 389 | 0.580 |
Why?
|
Eosinophilic Esophagitis | 2 | 2018 | 168 | 0.570 |
Why?
|
Proton Pump Inhibitors | 2 | 2023 | 526 | 0.530 |
Why?
|
Peptides | 2 | 2018 | 4410 | 0.520 |
Why?
|
Colitis | 2 | 2020 | 1170 | 0.520 |
Why?
|
Immunocompromised Host | 1 | 2020 | 847 | 0.490 |
Why?
|
Esophageal Diseases | 1 | 2015 | 167 | 0.490 |
Why?
|
Colonic Neoplasms | 2 | 2023 | 2542 | 0.470 |
Why?
|
Exophthalmos | 1 | 2015 | 97 | 0.470 |
Why?
|
Cavernous Sinus | 1 | 2015 | 125 | 0.460 |
Why?
|
Immunologic Factors | 2 | 2021 | 1580 | 0.440 |
Why?
|
Pancreatitis | 2 | 2023 | 1092 | 0.430 |
Why?
|
Immunosuppressive Agents | 3 | 2021 | 4153 | 0.420 |
Why?
|
Carotid Artery, Internal | 1 | 2015 | 445 | 0.420 |
Why?
|
Pyrroles | 1 | 2018 | 1146 | 0.410 |
Why?
|
Arteriovenous Fistula | 1 | 2015 | 315 | 0.400 |
Why?
|
Piperidines | 2 | 2022 | 1602 | 0.390 |
Why?
|
Eosinophilia | 1 | 2015 | 541 | 0.380 |
Why?
|
Quality of Life | 4 | 2024 | 12802 | 0.370 |
Why?
|
Ambulatory Care | 1 | 2021 | 2708 | 0.350 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1671 | 0.340 |
Why?
|
Humans | 60 | 2024 | 744366 | 0.330 |
Why?
|
Depression | 6 | 2020 | 7759 | 0.320 |
Why?
|
Patient Selection | 2 | 2021 | 4216 | 0.320 |
Why?
|
Biological Products | 3 | 2022 | 860 | 0.310 |
Why?
|
Thrombosis | 1 | 2022 | 2968 | 0.310 |
Why?
|
Aged | 22 | 2024 | 163288 | 0.300 |
Why?
|
Pyrimidines | 2 | 2022 | 2943 | 0.300 |
Why?
|
Vision Disorders | 1 | 2015 | 1058 | 0.300 |
Why?
|
Colorectal Neoplasms | 3 | 2023 | 6773 | 0.290 |
Why?
|
Antihypertensive Agents | 1 | 2015 | 2047 | 0.250 |
Why?
|
Cohort Studies | 8 | 2022 | 40559 | 0.250 |
Why?
|
Stents | 2 | 2023 | 3282 | 0.230 |
Why?
|
Internet | 1 | 2016 | 3056 | 0.230 |
Why?
|
Tumor Necrosis Factor-alpha | 5 | 2022 | 4424 | 0.230 |
Why?
|
Telemedicine | 1 | 2021 | 2872 | 0.230 |
Why?
|
Parenteral Nutrition | 2 | 2018 | 650 | 0.220 |
Why?
|
Adult | 22 | 2022 | 214052 | 0.220 |
Why?
|
Cholinergic Antagonists | 1 | 2024 | 165 | 0.220 |
Why?
|
Cost of Illness | 3 | 2023 | 1860 | 0.210 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5534 | 0.210 |
Why?
|
Prevalence | 4 | 2024 | 15221 | 0.200 |
Why?
|
Inappropriate Prescribing | 1 | 2024 | 202 | 0.200 |
Why?
|
Retrospective Studies | 13 | 2023 | 77460 | 0.200 |
Why?
|
Comorbidity | 5 | 2023 | 10388 | 0.200 |
Why?
|
Anti-Inflammatory Agents | 2 | 2021 | 1790 | 0.190 |
Why?
|
Biological Therapy | 1 | 2022 | 138 | 0.190 |
Why?
|
Male | 24 | 2022 | 350115 | 0.190 |
Why?
|
Middle Aged | 18 | 2022 | 213390 | 0.190 |
Why?
|
United States | 13 | 2023 | 69872 | 0.190 |
Why?
|
Los Angeles | 1 | 2021 | 238 | 0.190 |
Why?
|
Registries | 1 | 2016 | 8091 | 0.180 |
Why?
|
Incidence | 6 | 2023 | 20952 | 0.180 |
Why?
|
Female | 25 | 2022 | 380193 | 0.180 |
Why?
|
Patient Readmission | 3 | 2018 | 3116 | 0.170 |
Why?
|
Age Factors | 4 | 2021 | 18373 | 0.170 |
Why?
|
Insurance, Life | 1 | 2018 | 13 | 0.170 |
Why?
|
Treatment Outcome | 8 | 2022 | 63107 | 0.170 |
Why?
|
Anastomosis, Surgical | 2 | 2022 | 987 | 0.160 |
Why?
|
Young Adult | 10 | 2021 | 56429 | 0.160 |
Why?
|
Flatulence | 1 | 2017 | 20 | 0.160 |
Why?
|
Histocytochemistry | 1 | 2018 | 719 | 0.150 |
Why?
|
Health Care Costs | 2 | 2023 | 3208 | 0.150 |
Why?
|
Denmark | 1 | 2019 | 738 | 0.150 |
Why?
|
Insurance | 1 | 2018 | 111 | 0.140 |
Why?
|
Gases | 1 | 2017 | 197 | 0.140 |
Why?
|
Syndrome | 1 | 2023 | 3252 | 0.140 |
Why?
|
Aged, 80 and over | 6 | 2021 | 57776 | 0.140 |
Why?
|
Pancreatic Diseases | 1 | 2018 | 350 | 0.140 |
Why?
|
Postoperative Complications | 1 | 2018 | 15297 | 0.140 |
Why?
|
Severity of Illness Index | 4 | 2017 | 15535 | 0.130 |
Why?
|
Social Participation | 1 | 2017 | 173 | 0.130 |
Why?
|
Levobunolol | 1 | 2015 | 3 | 0.130 |
Why?
|
Time Factors | 6 | 2021 | 40075 | 0.130 |
Why?
|
Liver Cirrhosis | 2 | 2022 | 1862 | 0.130 |
Why?
|
Anxiety | 3 | 2020 | 4293 | 0.130 |
Why?
|
Fecal Incontinence | 1 | 2017 | 239 | 0.120 |
Why?
|
Drug Utilization | 1 | 2021 | 1183 | 0.120 |
Why?
|
Nausea | 1 | 2017 | 674 | 0.120 |
Why?
|
Dilatation | 1 | 2015 | 291 | 0.120 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 25039 | 0.120 |
Why?
|
Hospitalization | 3 | 2018 | 10259 | 0.120 |
Why?
|
Multivariate Analysis | 4 | 2021 | 12244 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2023 | 9955 | 0.120 |
Why?
|
Esophagoscopy | 1 | 2015 | 390 | 0.120 |
Why?
|
Ophthalmic Solutions | 1 | 2015 | 317 | 0.110 |
Why?
|
Risk Factors | 8 | 2023 | 72296 | 0.110 |
Why?
|
Personal Satisfaction | 1 | 2017 | 643 | 0.110 |
Why?
|
Logistic Models | 4 | 2021 | 13409 | 0.110 |
Why?
|
Quinoxalines | 1 | 2015 | 290 | 0.110 |
Why?
|
Constipation | 1 | 2017 | 546 | 0.110 |
Why?
|
Adolescent | 11 | 2021 | 85779 | 0.110 |
Why?
|
Antibodies | 1 | 2021 | 2460 | 0.110 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1856 | 0.110 |
Why?
|
Digestive System Surgical Procedures | 1 | 2017 | 576 | 0.100 |
Why?
|
Regression Analysis | 2 | 2021 | 6459 | 0.100 |
Why?
|
Drug Administration Schedule | 2 | 2021 | 4933 | 0.100 |
Why?
|
Deglutition Disorders | 1 | 2017 | 606 | 0.100 |
Why?
|
Abdominal Pain | 1 | 2017 | 1064 | 0.090 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39052 | 0.090 |
Why?
|
Medical Records | 1 | 2016 | 1413 | 0.090 |
Why?
|
Information Storage and Retrieval | 1 | 2016 | 824 | 0.090 |
Why?
|
Age of Onset | 1 | 2017 | 3270 | 0.090 |
Why?
|
Diarrhea | 1 | 2017 | 1348 | 0.090 |
Why?
|
Gastroesophageal Reflux | 1 | 2017 | 782 | 0.090 |
Why?
|
Steroids | 1 | 2015 | 930 | 0.090 |
Why?
|
Thiophenes | 1 | 2015 | 589 | 0.090 |
Why?
|
Fatigue | 1 | 2017 | 1531 | 0.090 |
Why?
|
Liver Diseases | 1 | 2018 | 1253 | 0.090 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 1170 | 0.090 |
Why?
|
Minority Groups | 1 | 2017 | 1221 | 0.090 |
Why?
|
Remission Induction | 1 | 2015 | 2385 | 0.090 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 12961 | 0.090 |
Why?
|
Cerebral Angiography | 1 | 2015 | 1285 | 0.080 |
Why?
|
Intraocular Pressure | 1 | 2015 | 1270 | 0.080 |
Why?
|
Odds Ratio | 2 | 2021 | 9849 | 0.080 |
Why?
|
Reoperation | 1 | 2018 | 4201 | 0.080 |
Why?
|
Case-Control Studies | 3 | 2021 | 21748 | 0.080 |
Why?
|
Intestines | 1 | 2017 | 1924 | 0.080 |
Why?
|
Hyperplasia | 2 | 2021 | 1185 | 0.080 |
Why?
|
Cognition | 2 | 2023 | 6770 | 0.080 |
Why?
|
Ileum | 2 | 2023 | 565 | 0.080 |
Why?
|
Antidepressive Agents | 1 | 2019 | 2838 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12356 | 0.070 |
Why?
|
Health Status | 1 | 2020 | 4034 | 0.070 |
Why?
|
Self Report | 1 | 2017 | 3553 | 0.070 |
Why?
|
Disease Progression | 1 | 2023 | 13286 | 0.070 |
Why?
|
Recurrence | 1 | 2017 | 8340 | 0.070 |
Why?
|
Health Expenditures | 1 | 2018 | 2349 | 0.070 |
Why?
|
Phenotype | 2 | 2020 | 16367 | 0.070 |
Why?
|
Sulfonamides | 1 | 2015 | 1940 | 0.060 |
Why?
|
Skin | 1 | 2018 | 4372 | 0.060 |
Why?
|
Prognosis | 4 | 2019 | 29060 | 0.060 |
Why?
|
Prospective Studies | 5 | 2023 | 53290 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11366 | 0.060 |
Why?
|
Length of Stay | 1 | 2017 | 6311 | 0.060 |
Why?
|
Smoking | 1 | 2021 | 8987 | 0.060 |
Why?
|
Geriatric Assessment | 2 | 2022 | 1372 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7182 | 0.060 |
Why?
|
Medicare | 1 | 2021 | 6566 | 0.060 |
Why?
|
Colonoscopy | 2 | 2021 | 1367 | 0.060 |
Why?
|
Child, Preschool | 3 | 2022 | 41005 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3154 | 0.060 |
Why?
|
Quality Improvement | 1 | 2018 | 3749 | 0.060 |
Why?
|
I-kappa B Proteins | 1 | 2002 | 225 | 0.050 |
Why?
|
Colon | 2 | 2023 | 1772 | 0.050 |
Why?
|
Child | 5 | 2020 | 77709 | 0.050 |
Why?
|
Research Design | 1 | 2016 | 5984 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2020 | 25628 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15078 | 0.040 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2021 | 297 | 0.040 |
Why?
|
Cholangitis, Sclerosing | 1 | 2021 | 160 | 0.040 |
Why?
|
Biopsy | 2 | 2021 | 6755 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 23336 | 0.040 |
Why?
|
Infant | 1 | 2020 | 35134 | 0.040 |
Why?
|
Independent Living | 1 | 2022 | 568 | 0.040 |
Why?
|
Diet | 1 | 2015 | 7937 | 0.040 |
Why?
|
Frail Elderly | 1 | 2022 | 693 | 0.040 |
Why?
|
Hospital Charges | 1 | 2017 | 362 | 0.030 |
Why?
|
NF-kappa B | 1 | 2002 | 2499 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2002 | 2969 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2016 | 940 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2023 | 1862 | 0.030 |
Why?
|
Needs Assessment | 1 | 2018 | 1147 | 0.030 |
Why?
|
Databases, Factual | 2 | 2017 | 7730 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2021 | 3773 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2017 | 867 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20130 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2021 | 6171 | 0.020 |
Why?
|
Aspirin | 1 | 2023 | 3283 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2018 | 1410 | 0.020 |
Why?
|
Neutrophils | 1 | 2002 | 3721 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2022 | 6994 | 0.020 |
Why?
|
Insurance, Health | 1 | 2021 | 2494 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9145 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10400 | 0.020 |
Why?
|
Apoptosis | 1 | 2002 | 9724 | 0.020 |
Why?
|
Animals | 1 | 2018 | 168768 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 9647 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7785 | 0.020 |
Why?
|
Inflammation | 1 | 2023 | 10637 | 0.010 |
Why?
|
Neutrophil Activation | 1 | 2002 | 186 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5135 | 0.010 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2002 | 443 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9445 | 0.010 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2002 | 546 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 12073 | 0.010 |
Why?
|
Cytoplasm | 1 | 2002 | 1536 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2016 | 12262 | 0.010 |
Why?
|
Monocytes | 1 | 2002 | 2596 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2002 | 19233 | 0.000 |
Why?
|